Cancer research
Researchers at the Medical University of Vienna discovered that ZNF677 is downregulated in non-small cell lung cancers (NSCLC) due to tumor-specific methylation. This study investigated the role of ZNF677 in NSCLC by comparing its expression in primary tumor and non-malignant lung tissue samples from 1,000 patients. The results showed
Cancer research
Research has shown that signals released by leukocytes contribute to tumor growth and influence the efficacy of antineoplastic treatments. A study published in the International Journal of Cancer found that chemotherapy can activate events that have deleterious effects in the long term. The study also identified autophagy induction and High
Cancer research
Research conducted by scientists at Fujian Medical University has led to the development of a novel enzyme-free and label-free fluorescent biosensor for detecting liver cancer-related short genes in human serum. This method has shown significant promise in improving survival rates by enabling early diagnosis of liver cancer. The sensor utilizes
Cancer research
A recent study published in Environmental Research has found that polymorphisms in the XRCC1 and XRCC3 genes may modify the associations between skin cancer risk and exposure to sunlight or arsenic. The study, conducted in Europe, analyzed data from 618 new cases of non-melanoma skin cancer and 527 hospital-based controls
Cancer research
Research presented from Mie, Japan, has highlighted the potential of epigenetic biomarkers, particularly DNA methylation and non-coding RNAs, in the early detection of gastric and colorectal cancer. According to a study published in Biochemical and Biophysical Research Communications, epigenetic alterations play a crucial role in cancer initiation and progression, and
Cancer
Research from the Institute for Cancer Research and Treatment (IRCCS) in Padua, Italy, has shed light on the role of inflammation in cancer development. The study found that mutant p53, a common mutation in cancer cells, can reprogram TNF signaling through interaction with the tumor suppressor DAB2IP, leading to increased
Cancer
Researchers at the Ludwig Boltzmann Institute for Applied Cancer Research in Vienna, Austria, have shed new light on the molecular mechanisms underlying genomic instability. By investigating the role of unresolved replication intermediates, they found that these structures can block the progression of replication forks and become converted into DNA lesions,
Cancer research
Researchers at the University of Palermo have made significant progress in understanding the mechanisms of apoptosis, or programmed cell death, in cancer cells. By sequencing and analyzing the cell cycle dynamics of cancer cells, the team identified universal mechanisms of apoptosis that can be replicated in silico. This breakthrough has
Cancer research
Researchers from the University of Southern California, Norris Comprehensive Cancer Center, have made a significant breakthrough in the development of a novel cancer vaccine. According to their study, a Heat Shock Protein 70 (HSP70)-based DNA vaccine, combined with a modified Mage3 gene, induces both innate and adaptive immune responses,
Cancer treatment
Peroxynitrite, a molecule linked to carcinogenesis, has been studied in relation to its potential in causing DNA strand breaks. Researchers in the United States have investigated the role of aspirin, a widely used anti-inflammatory drug, in inhibiting peroxynitrite-mediated DNA damage. The study, published in Biochemical and Biophysical Research Communications, demonstrated
Cancer treatment
Researchers have made a significant breakthrough in understanding the role of CAAX-mediated posttranslational processing in Rheb localization and signaling. The study, published in Oncogene, reveals that although CAAX-mediated processing is necessary for Rheb localization, it is dispensable for Rheb-induced activation of the mTOR substrate p70 S6 kinase (S6K). Furthermore, the
Cancer research
Researchers in Korea have made a significant breakthrough in the fight against lung cancer with the development of a novel genetic immunotherapy approach. The study, published in Cancer Gene Therapy, demonstrates the efficacy of combining conditionally replicating adenovirus (CRAd) and replication-defective adenovirus expressing interferon-beta (ad-IFN-beta) in treating lung cancer. This
